138.99
Genedx Holdings Corp stock is traded at $138.99, with a volume of 99,017.
It is up +2.11% in the last 24 hours and up +4.17% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$136.32
Open:
$136.55
24h Volume:
99,017
Relative Volume:
0.19
Market Cap:
$4.02B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-44.69
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-8.12%
1M Performance:
+4.17%
6M Performance:
+116.05%
1Y Performance:
+84.86%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
139.10 | 3.94B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
567.26 | 211.29B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.28 | 158.47B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
703.79 | 55.66B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
137.47 | 38.75B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.72 | 37.90B | 15.90B | 1.28B | 2.21B | 7.2842 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
Is GeneDx Holdings Corp. Equity Warrant stock attractive for income investors2025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда
Why GeneDx Holdings Corp. stock could rally in 2025Quarterly Profit Report & Accurate Entry and Exit Point Alerts - DonanımHaber
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 10,857 Shares - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 3,855 Shares of Stock - MarketBeat
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
Can GeneDx Holdings Corp. Equity Warrant stock surprise with earnings upsideJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - Улправда
Is GeneDx Holdings Corp. Equity Warrant stock a safe buy before earningsPortfolio Value Report & Fast Entry Momentum Alerts - Улправда
GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
GeneDx (NASDAQ:WGS) Stock Price Down 6.4%What's Next? - MarketBeat
WGS: Wells Fargo Raises Price Target to $155, Maintains Equal-We - GuruFocus
GeneDx (Nasdaq: WGS) genomic newborn study in JAMA list after 20K screens - Stock Titan
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Be 40% Below Their Intrinsic Value Estimate - Yahoo Finance
Ashford Capital Management Inc. Buys 77,310 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Liquidity Mapping Around (WGS) Price Events - news.stocktradersdaily.com
BTIG Research Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
GeneDx Holdings Corp Stock Analysis and ForecastEarnings Growth Patterns & Access Insider-Level Stock Analysis - earlytimes.in
Katherine Stueland Sells 3,639 Shares of GeneDx (NASDAQ:WGS) Stock - MarketBeat
GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 1,266 Shares - MarketBeat
BTIG Maintains GeneDx Holdings (WGS) Buy Recommendation - Nasdaq
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView — Track All Markets
Genedx Holdings Insider Sold Shares Worth $579,620, According to a Recent SEC Filing - marketscreener.com
GeneDx Holdings Corp.'s (NASDAQ:WGS) P/S Is On The Mark - 富途牛牛
Next Century Growth Investors LLC Has $20.46 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Norges Bank Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat
Ardsley Advisory Partners LP Takes $7.39 Million Position in GeneDx Holdings Corp. $WGS - MarketBeat
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump - The Motley Fool
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump - The Motley Fool
Legal & General Group Plc Increases Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Cathie Wood’s ARK Sells Tesla Stock, Adds to Baidu and GeneDx Holdings - Investing.com India
Is GeneDx Holdings Corp a good long term investmentEarnings Season Recap & Free Triple Digit Wealth Increase - earlytimes.in
GeneDx Holdings Corp. $WGS Shares Purchased by Rhumbline Advisers - MarketBeat
New York State Common Retirement Fund Sells 30,541 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Bosun Asset Management LLC Sells 15,918 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Is Metalyst Forgings Limited One of the Top Picks for Growth Investors in YEARDividend Growth Stocks & Add These Before Everyone Else Does - earlytimes.in
Why GeneDx Holdings Corp. Equity Warrant stock could benefit from AI revolutionTrade Risk Assessment & Low Risk High Reward Ideas - Newser
Cathie Wood Targets Genomics and Self-Driving Tech with GeneDx and WeRide Stock Buys - parameter.io
Cathie Wood’s ARK Invest Shifts Portfolio with GeneDx and WeRide Purchases - Blockonomi
Russell Investments Group Ltd. Sells 27,413 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Cathie Wood Bets Big on Autonomous Driving with WeRide Stock Purchase - CoinCentral
Prudential Financial Inc. Sells 44,738 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Can GeneDx Holdings Corp. Equity Warrant stock maintain growth trajectory2025 Market Outlook & Community Supported Trade Ideas - Newser
WGS, WRD, IRDM: Cathie Wood Ramps Up Buying in GeneDx and WeRide, Trims Exposure in Iridium stock - TipRanks
Cathie Wood’s ARK sells Iridium, buys GeneDx and WeRide stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK sells Iridium, buys GeneDx and WeRide stock - Investing.com
Feeley, GeneDx CFO, sells $61,276 in WGS stock By Investing.com - Investing.com Canada
Feeley, GeneDx CFO, sells $61,276 in WGS stock - Investing.com
GeneDx Holdings Corp. CFO Kevin Feeley Sells Shares to Cover Tax Obligations - TradingView
GeneDx (NASDAQ:WGS) Sets New 52-Week HighHere's Why - MarketBeat
Is Asit C Mehta Financial Services Limited Stock a Strong Buy According to Wall StreetMarket Liquidity Analysis & Discover Strategies with Fellow Traders - earlytimes.in
What Wall Street predicts for GeneDx Holdings Corp. Equity Warrant stock priceWeekly Risk Summary & Growth Focused Stock Pick Reports - Newser
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 16 '25 |
Sale |
143.87 |
3,855 |
554,616 |
8,731 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Dec 16 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
25,094 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Dec 16 '25 |
Sale |
143.89 |
10,857 |
1,562,185 |
14,237 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 09 '25 |
Option Exercise |
0.00 |
2,462 |
0 |
6,655 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 09 '25 |
Sale |
159.28 |
1,266 |
201,648 |
5,389 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Dec 09 '25 |
Option Exercise |
0.00 |
6,547 |
0 |
9,983 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Dec 09 '25 |
Sale |
159.28 |
3,639 |
579,620 |
6,344 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 01 '25 |
Option Exercise |
0.00 |
717 |
0 |
4,570 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 01 '25 |
Sale |
162.54 |
377 |
61,276 |
4,193 |
| RUCH JOSHUA | Director |
Nov 24 '25 |
Sale |
160.37 |
38,000 |
6,093,967 |
11,941 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):